| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.47 | 0.001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.46 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |